Partnership
philips-healthcare x nvidia
Philips Healthcare partners with NVIDIA for AI-powered medical imaging and clinical decision support
technology · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/philips-healthcare-x-nvidia.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/philips-healthcare-x-nvidia
- Revision history: /partnerships/philips-healthcare-x-nvidia/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
f496f9b6-07a2-4295-81fb-90a4a5a7f420- Type
- technology
- Status
- Activeoperating
Who’s involved
Philips Healthcare is a division of Royal Philips (NYSE: PHG) developing medical imaging, patient monitoring, and AI-powered diagnostics. Developing robotic-assisted imaging systems and AI clinical decision support. Part of Philips' health technology portfolio.
World leader in accelerated computing and AI (NASDAQ: NVDA). In physical AI, NVIDIA develops the Isaac robotics platform: the GR00T open foundation model, Jetson edge compute (AGX Thor), Isaac Lab and Isaac Sim simulation environments, and Omniverse. NVIDIA positions itself as the platform layer for the humanoid industry. Developer of [GR00T N1](/brains/gr00t-n1), the first open humanoid foundation model.
Most-frequent partners
Related partnerships
Other partnerships of Philips Healthcare
- technology—operating
- technology—operating
- Philips x WellSpan Health (Strategic Alliance)Philips Healthcare + WellSpan Healthdevelopment2026-08-01operating
Other partnerships of NVIDIA
- technology—operating
- technology—operating
- technology—operating
- technology—operating
- technology—operating
Recent partnerships of the same kind
- technology—operating
- technology—operating
- technology—just announced
- loram x One Big CircleLoram + One Big Circletechnology—operating
- iron-mountain-data-centers x Check Point SoftwareIron Mountain Data Centers + Check Point Softwaretechnology—operating
- technology—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.